Fondaparinux Sodium 00781-3465
Product NDC
00781-3465- Manufacturer
- Sandoz Inc.
- Dosage Form
- Injection
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- June 18, 2019
- Listing Expires
- December 31, 2026
- Application
- ANDA206812
Need to source Fondaparinux Sodium? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Fondaparinux Sodium | 7.5 mg/.6mL |
Drug Class
Factor Xa Inhibitor [EPC]Factor Xa Inhibitors [MoA]
Packaging Options(2)
2 SYRINGE in 1 CARTON (0781-3465-12) / .6 mL in 1 SYRINGE (0781-3465-94)
10 SYRINGE in 1 CARTON (0781-3465-95) / .6 mL in 1 SYRINGE (0781-3465-94)